5 European Projects Found
Searched on 125080 European Projects
FINISHED
A Gateway to European Kidney Research Resources - KidneyConnect (KidneyConnect)
Start date: Aug 1, 2013, End date: Jul 31, 2016,
Diabetes, Cardiovascular and Chronic kidney (DCC) -diseases are relentlessly increasing globally, causing enormous human suffering, premature deaths and unsustainable costs. Leading European research has indisputably pointed that the kidney filtration barrier and its epithelial cell, the podocyte, is a common denominator for the DCC-diseases. However, European excellence and expertise have remaine ...
Read Project
19
Partners Participants
FINISHED
Infectious triggers of chronic autoimmunity (INTRICATE)
Start date: Nov 1, 2010, End date: Apr 30, 2015,
This proposal builds on existing expertise and collaborations of a multidisciplinary Consortium of basic scientists and clinical investigators each of whom has made a substantial individual contribution to understanding the links between infection and autoimmunity. The aim of the INTRICATE Consortium is to prosecute a programme of Translational Research that deliniates the role of infection in the ...
Read Project
13
Partners Participants
FINISHED
The role of the transcription factor GATA3 in kidney function and disease (GATA3 in KIDNEY)
Start date: May 1, 2013, End date: Apr 30, 2015,
Mutations in GATA3, a dual zinc-finger transcription factor, cause the autosomal dominant hypoparathyroidism, deafness, renal dysplasia (HDR) syndrome, and down-regulation of GATA3 results in clear cell renal cell carcinoma. The renal abnormalities in HDR patients consist of cysts, renal aplasia/hypoplasia, mesangioproliferative glomerulonephritis, and vesicoureteral reflux. In the developing kid ...
Read Project
1
Partner Participant
FINISHED
Translational Science for Vascular Inflammation and Remodelling (TranSVIR)
Start date: Dec 1, 2009, End date: Nov 30, 2013,
The rapid advance of biology is providing new insights into the causes of some of today’s most pressing medical problems as well as huge opportunities to develop and evaluate novel and more effective treatments. The challenge is to exploit these advances effectively and this will require a new breed of translational scientist with expertise in a specific discipline coupled with a broad understandi ...
Read Project
6
Partners Participants
FINISHED
Evaluation of epigenetic biomarkers in prostate cancer patients before and after hormone ablation therapy (Epigenetic marker)
Start date: Nov 1, 2009, End date: Oct 31, 2012,
Prostate cancer is among the leading tumor types in men in the Western world. The heterogeneity of prostate cancer provides difficulties in tumor classification and decision-making for therapies. The establishment of new biomarkers is essential to develop individual treatments and facilitate tumor categorization. Therapies include hormone deprivation, which initially leads to tumor regression, but ...
Read Project
